A Randomized, Double-Blind, Dose Response Phase 2 Pilot Study of Manualized MDMA-Assisted Psychotherapy in Subjects With Chronic, Treatment-Resistant Posttraumatic Stress Disorder (PTSD)
Latest Information Update: 08 Jan 2024
At a glance
- Drugs Methylenedioxymetamfetamine (Primary)
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- Sponsors Lykos Therapeutics
- 19 Jan 2023 According to a MAPS media release, results from the trial were published in the journal Frontiers in Psychiatry.
- 19 Jan 2023 Results published in a MAPS media release.
- 07 Jun 2017 Status changed from Active, not recruiting to completed.